Back
ESC Premium Access

Advantage of novel oral anticoagulants compared to vitamin-K antagonist in atrial fibrillation. Data from real world.

Session: Poster Session 5 - Atrial fibrillation - Stroke prevention 2
Topic: Oral Anticoagulation
Speaker: Doctor G. Simonyi (Budapest, HU)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Gabor Antal Simonyi

St Imre University Teaching Hospital, Budapest (Hungary)
0 follower

10 more presentations in this session

Antithrombotic management in patients with atrial fibrillation and acute coronary syndromes

Speaker: Associate Professor B. Hudzik (Zabrze, PL)

Access
Abstract
Slides
Thumbnail

Prior antithrombotic therapy: a snapshot of 17,769 patients from the global edoxaban treatment in routine clinical practice in patients with non-valvular atrial fibrillation programme (global ETNA-AF)

Speaker: Professor R. De Caterina (Pisa, IT)

Access
Abstract
Slides
Thumbnail

Oral anticoagulation continuation vs. discontinuation after catheter-ablation of paroxysmal atrial fibrillation - incidence of cerebral insults and severe hemorrhagic complications

Speaker: Ms L. Pracht (Munich, DE)

Access
Abstract
Thumbnail

A new score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs

Speaker: Doctor O. Rutherford (Sarpsborg, NO)

Access
Abstract
Slides
Thumbnail

Difference of efficacy and safety of left atrial appendage closure using watchman between patients aged less than 75 to more than 75 years

Speaker: Doctor J. Yu (Lichtenfels, DE)

Access
Abstract
Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation - Stroke prevention 2

Speakers: Doctor G. Simonyi, Associate Professor B. Hudzik, Professor R. De Caterina, Ms L. Pracht, Doctor O. Rutherford...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb